A Phase II Trial of Erlotinib Monotherapy for Pretreated Elderly Patients With Advanced EGFR Wild-Type Non-Small Cell Lung Cancer
BMC Research Notes - United Kingdom
doi 10.1186/s13104-015-1214-9
Full Text
Open PDFAbstract
Available in full text
Date
June 5, 2015
Authors
Publisher
Springer Science and Business Media LLC